Social Anxiety Disorders (SAD) Therapeutics - Pipeline

Assessment and Market Forecasts to 2019

On 23rdDecember 2014

Summary
The industry analysis specialist, has released its new report, Social Anxiety Disorders (SAD)
Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential
source of information and analysis on the global Social Anxiety Disorders (SAD) Therapeutics
market. The report identifies the key trends shaping and driving the global Social Anxiety
Disorders (SAD) Therapeutics market. The report also provides insights on the prevalent
competitive landscape and the emerging players expected to significantly alter the market
positioning of the current market leaders. Most importantly, the report provides valuable
insights on the pipeline products within the global Social Anxiety Disorders (SAD) Therapeutics
sector. This report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GlobalDatas team of industry
experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-social-anxiety-disorders-sad-therapeutics-pipeline-assessment-andmarket-forecasts-135215

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Scope
The report provides information on the key drivers and challenges of the Social Anxiety
Disorders (SAD) Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Social Anxiety
Disorders (SAD) Therapeutics market revenues data from 2006 to 2011, forecast for eight years
to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Social Anxiety
Disorders (SAD) Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Social Anxiety Disorders (SAD) Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Social Anxiety Disorders (SAD)
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Social
Anxiety Disorders (SAD) Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Social Anxiety Disorders (SAD)
Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
- Whats the next big thing in the global Social Anxiety Disorders (SAD) Therapeutics market
landscape? Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Social Anxiety Disorders (SAD) Therapeutics - Introduction
2.1 Overview
2.1.1 Types of SAD
2.2 Etiology and Pathophysiology
2.3 Epidemiology
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.3.1 The US
2.3.2 Spain
2.3.3 Italy
2.3.4 Japan
2.3.5 Germany
2.3.6 France
2.3.7 Pharmaco-economic Burden
2.3.8 Quality of Life (QoL)
2.3.9 Morbidity
2.4 Symptoms
2.5 Diagnosis
2.5.1 Diagnostic Criteria for SAD Defined by DSM-IV
2.5.2 Measurement Scales
2.6 Treatment and Management Pattern
2.6.1 Psychological Treatment
2.6.2 Pharmacologic Treatment
2.7 Referral Pathway
2.8 GlobalData Pipeline Report Guidance
3 SAD Therapeutics - Market Characterization
3.1 Overview
3.2 SAD Therapeutics Market Size (2006-2011) - Global
3.3 SAD Therapeutics Market Forecast (2011-2019) - Global
3.4 SAD Therapeutics Market Size (2006-2011) - The US
3.5 SAD Therapeutics Market Forecast (2011-2019) - The US
3.6 SAD Therapeutics Market Size (2006-2011) - France
3.7 SAD Therapeutics Market Forecast (2011-2019) - France
3.8 SAD Therapeutics Market Size (2006-2011) - Germany
3.9 SAD Therapeutics Market Forecast (2011-2019) - Germany
3.10 SAD Therapeutics Market Size (2006-2011) - Italy
3.11 SAD Therapeutics Market Forecast (2011-2019) - Italy
3.12 SAD Therapeutics Market Size (2006-2011) - Spain
3.13 SAD Therapeutics Market Forecast (2011-2019) - Spain
3.14 SAD Therapeutics Market Size (2006-2011) - The UK
3.15 SAD Therapeutics Market Forecast (2011-2019) - The UK
3.16 SAD Therapeutics Market Size (2006-2011) - Japan
3.17 SAD Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers
3.18.1 Drivers for the SAD Therapeutics Market
3.18.2 Barriers for the SAD Therapeutics Market
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3.19 Opportunity and Unmet Needs

3.20 Key Takeaway
4 SAD Therapeutics Market - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the SAD Therapeutics Market
4.3.1 SSRIs
4.3.2 SNRIs
4.3.3 Benzodiazepines
4.3.4 Monoamine Oxidase Inhibitors
4.4 Key Takeaway
5 SAD Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Pipeline by Phases of Development
5.3.1 SAD Therapeutics-Phase II Pipeline
5.3.2 SAD Therapeutics- Phase I Pipeline
5.4 SAD Therapeutics Market - Clinical Pipeline by Mechanism of Action.
5.5 Technology Trends Analytic Framework
5.6 Promising Drugs under Clinical Development
5.7 Profiles of Promising Drugs
5.7.1 CXB722
5.7.2 PH94B
5.7.3 TGW00AA
5.8 Key Takeaway
6 SAD Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Top Companies Participating in Therapeutics Clinical Trials
7 SAD Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 SAD Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 CeNeRx BioPharma
8.2.2 Fabre-Kramer Pharmaceuticals, Inc
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

8.2.3 Pherin Pharmaceuticals

8.3 Other Companies in the SAD Therapeutics Market
9 SAD Therapeutics - Licensing and Partnership Deals
10 Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: FDA and EMEA Approved Medications for the Treatment of SAD
Table 2: SAD Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 3: SAD Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 4: SAD Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 5: SAD Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 6: SAD Therapeutics Market, France, Revenue ($m), 2006-2011
Table 7: SAD Therapeutics Market, France, Forecast ($m), 2011-2019
Table 8: SAD Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 9: SAD Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 10: SAD Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 11: SAD Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 12: SAD Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 13: SAD Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 14: SAD Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 15: SAD Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 16: SAD Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 17: SAD Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 18: Treatment-Emergent Adverse Event Incidence in Short-Term Placebo-Controlled
Effexor XR Clinical Trials in SAD Patients
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 19: SAD Therapeutics-Phase II Pipeline

Table 20: SAD Therapeutics-Phase I Pipeline
Table 21: SAD Therapeutics - Most Promising Drugs Under Clinical Development, 2011
Table 22: SAD Therapeutics Market, Number of Clinical Trials by Region, 2011
Table 23: SAD Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2011
Table 24: SAD Therapeutics Market, Global, Clinical Trials by Trial Status (%), 2011
Table 25: SAD Therapeutics Market, Global, Clinical Trials by Prominent Sponsors (%), 2011
Table 26: SAD Therapeutics Market, Global, Number of Clinical Trials by Top Companies, 2011
Table 27: CeNeRx BioPharma - CNS Pipeline Products, 2011
Table 28: CeNeRx BioPharma - SAD Pipeline Products, 2011
Table 29: Fabre-Kramer Pharmaceuticals - CNS Pipeline Products, 2011
Table 30: Fabre-Kramer Pharmaceuticals - SAD Pipeline Products, 2011
Table 31: Pherin Pharmaceuticals - CNS Pipeline Products, 2011
Table 32: Pherin Pharmaceuticals - SAD Pipeline Products, 2011
Table 33: SAD Therapeutics Market - Future Players, 2011
Table 34: SAD Therapeutics, Global, Deals, 2009-2011

List Of Figures
Figure 1: SAD Treatment Options
Figure 2: Referral Pathway for SAD
Figure 3: SAD Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 4: SAD Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 5: SAD Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 6: SAD Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 7: SAD Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 8: SAD Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 9: SAD Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 10: SAD Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 11: SAD Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 12: SAD Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 13: SAD Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 14: SAD Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 15: SAD Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 16: SAD Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 17: SAD Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 18: SAD Therapeutics Market, Japan, Forecast ($m), 2011-2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 19: Opportunity and Unmet Need in the SAD Therapeutics Market, 2011
Figure 20: Strategic Competitor Assessment of the Major Marketed Products in SAD, 2011
Figure 21: SAD Therapeutics Pipeline by Phases of Clinical Development (%), 2011
Figure 22: SAD Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011
Figure 23: Technology Trends Analytic Framework of the SAD Therapeutics Pipeline, 2011
Figure 24: Technology Trends Analytic Framework of the SAD Therapeutics Pipeline Description, 2011
Figure 25: CXB722 Clinical Trial Details
Figure 26: PH94B Clinical Trial Details
Figure 27: TWG00AA Clinical Trial Details
Figure 28: SAD Therapeutics Market, Number of Clinical Trials by Region, 2011
Figure 29: SAD Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2011
Figure 30: SAD Therapeutics Market, Global, Clinical Trials by Trial Status (%), 2011
Figure 31: SAD Therapeutics Market, Global, Clinical Trials by Overall Sponsors (%), 2011
Figure 32: SAD Therapeutics Market, Global, Clinical Trials by Prominent Sponsors (%), 2011
Figure 33: SAD Therapeutics Market, Global, Number of Clinical Trials by Top Companies, 2011
Figure 34: SAD Therapeutics Market, Drivers and Restraints, 2011
Figure 35: Implications for Future Market Competition in the SAD Therapeutics Market, 2011
Figure 36: SAD Therapeutics Market, Clinical Pipeline by Company, 2011
Figure 37: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Social Anxiety Disorders (SAD) Therapeutics - Pipeline

Assessment and Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-social-anxietydisorders-sad-therapeutics-pipeline-assessment-and-market-forecasts-135215

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/